JP Stock MarketDetailed Quotes

206A Prism Biolab

Watchlist
  • 324
  • +14+4.52%
20min DelayTrading Nov 19 13:20 JST
11.65BMarket Cap-21739P/E (Static)

Prism Biolab Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Sep 30, 2023
(FY)Sep 30, 2022
Operating cash flow (Indirect Method)
Cash from operating activities
-592.95%-513M
104.07M
Net profit before non-cash adjustment
-808.91%-525.7M
--74.16M
Total adjustment of non-cash items
1,023.39%32.57M
---3.53M
-Depreciation and amortization
623.26%8.74M
--1.21M
-Reversal of impairment losses recognized in profit and loss
524.47%28.15M
--4.51M
-Disposal profit
--2K
--0
-Net exchange gains and losses
98.68%-138K
---10.49M
-Other non-cash items
-436.60%-4.18M
--1.24M
Changes in working capital
-159.42%-19.87M
--33.44M
-Change in receivables
206.42%21.72M
---20.41M
-Change in prepaid assets
468.38%4.66M
--819K
-Change in payables
-50.27%8.23M
--16.55M
-Change in accrued expense
114.17%2.57M
--1.2M
-Changes in other current assets
-261.68%-57.04M
--35.28M
Dividends paid (cash flow from operating activities)
Dividends received (cash flow from operating activities)
Interest paid (cash flow from operating activities)
Interest received (cash flow from operating activities)
-9.52%19K
21K
Tax refund paid
0.25%-1.21M
-1.21M
Other operating cash inflow (outflow)
338.37%377K
86K
Operating cash flow
-599.03%-513.81M
--102.96M
Investing cash flow
Net PPE purchase and sale
-505.06%-34.59M
---5.72M
Net changes in other investments
-168.24%-5.79M
---2.16M
Investing cash flow
-412.79%-40.38M
---7.87M
Financing cash flow
Net common stock issuance
--0
--210.87M
Net other fund-raising expenses
----
---100M
Financing cash flow
--0
--110.87M
Net cash flow
Beginning cash position
14.71%1.69B
--1.47B
Current changes in cash
-369.08%-554.19M
--205.96M
Effect of exchange rate changes
-98.68%138K
--10.49M
Cash adjustments other than cash changes
----
--1K
End cash Position
-32.82%1.13B
--1.69B
Free cash flow
-663.94%-548.4M
--97.25M
Currency Unit
JPY
JPY
Accounting Standards
NonUS-GAAP
NonUS-GAAP
(FY)Sep 30, 2023(FY)Sep 30, 2022
Operating cash flow (Indirect Method)
Cash from operating activities -592.95%-513M104.07M
Net profit before non-cash adjustment -808.91%-525.7M--74.16M
Total adjustment of non-cash items 1,023.39%32.57M---3.53M
-Depreciation and amortization 623.26%8.74M--1.21M
-Reversal of impairment losses recognized in profit and loss 524.47%28.15M--4.51M
-Disposal profit --2K--0
-Net exchange gains and losses 98.68%-138K---10.49M
-Other non-cash items -436.60%-4.18M--1.24M
Changes in working capital -159.42%-19.87M--33.44M
-Change in receivables 206.42%21.72M---20.41M
-Change in prepaid assets 468.38%4.66M--819K
-Change in payables -50.27%8.23M--16.55M
-Change in accrued expense 114.17%2.57M--1.2M
-Changes in other current assets -261.68%-57.04M--35.28M
Dividends paid (cash flow from operating activities)
Dividends received (cash flow from operating activities)
Interest paid (cash flow from operating activities)
Interest received (cash flow from operating activities) -9.52%19K21K
Tax refund paid 0.25%-1.21M-1.21M
Other operating cash inflow (outflow) 338.37%377K86K
Operating cash flow -599.03%-513.81M--102.96M
Investing cash flow
Net PPE purchase and sale -505.06%-34.59M---5.72M
Net changes in other investments -168.24%-5.79M---2.16M
Investing cash flow -412.79%-40.38M---7.87M
Financing cash flow
Net common stock issuance --0--210.87M
Net other fund-raising expenses -------100M
Financing cash flow --0--110.87M
Net cash flow
Beginning cash position 14.71%1.69B--1.47B
Current changes in cash -369.08%-554.19M--205.96M
Effect of exchange rate changes -98.68%138K--10.49M
Cash adjustments other than cash changes ------1K
End cash Position -32.82%1.13B--1.69B
Free cash flow -663.94%-548.4M--97.25M
Currency Unit JPYJPY
Accounting Standards NonUS-GAAPNonUS-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
JP
Overall
Symbol
Latest Price
% Chg

No Data